BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2009
View Archived Issues
Cell-based influenza H7 pandemic vaccine safe and immunogenic in phase I trial
Read More
Novel nitric oxide synthase inhibitors developed for the prevention of cerebral palsy
Read More
Novel candidates for the treatment of psoriasis display clinical efficacy and safety
Read More
Novel SCD inhibitors discovered by Daiichi Sankyo
Read More
Shire withdraws European MAA for Daytrana transdermal system
Read More
Avexa reports 96-week data from phase IIb apricitabine trial in HIV
Read More
Clavis Pharma announces phase II elacytarabine results
Read More
GE Healthcare claims novel iodine-containing contrast agents
Read More
Novel macrocyclic serine protease inhibitors developed by Idenix Pharmaceuticals
Read More
Merck KGaA presents novel tyrosinase inhibitors
Read More
Orally active synthetic androgen shows promise as male contraceptive in vivo
Read More
Astellas Pharma presents novel 5-HT5A receptor ligands
Read More
Healthpoint initiates phase II study for cell-based venous leg ulcer therapy
Read More
beta-Secretase inhibitors reduce amyloid load in rodent models of Alzheimer's disease
Read More
XenoPort receives milestone payments for FDA acceptance of Solzira NDA
Read More
Unigene reports phase I PTH results with improved formulation
Read More
European Commission approves acquisition of Ciba by BASF
Read More
Samtheo and Moffitt sign license agreement for Akt inhibitor LD-101
Read More
Concert presents encouraging results from phase I CTP-347 trial
Read More
Migenix reports top-line results for Omigard in catheter-related infections
Read More
Durect reports phase IIb results for Transdur-Sufentanil in pain
Read More
PharmaGap and MD Biosciences sign collaboration agreement for PKCtheta inhibitors
Read More
Avanir completes enrollment into phase III STAR trial of Zenvia in PBA
Read More
Probable delay in FDA's regulatory review of United Therapeutics' NDA for Tyvaso
Read More
Helix receives approval to initiate phase II pharmacokinetic study of interferon alpha-2b
Read More